Krystal Biotech
KRYS
KRYS
137 hedge funds and large institutions have $1.36B invested in Krystal Biotech in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 46 increasing their positions, 52 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% less capital invested
Capital invested by funds: $1.37B → $1.36B (-$961K)
0.63% less ownership
Funds ownership: 81.7% → 81.07% (-0.63%)
12% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 52
Holders
137
Holding in Top 10
5
Calls
$9.2M
Puts
$3.87M
Top Buyers
| 1 | +$15M | |
| 2 | +$6.08M | |
| 3 | +$5.84M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$5.44M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$4.6M |
Top Sellers
| 1 | -$9.59M | |
| 2 | -$8.03M | |
| 3 | -$4.92M | |
| 4 |
Jennison Associates
New York
|
-$4.54M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$4.02M |